High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic β-cells in normal men

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2621-2626

  Matsumoto, Kazunari ^a,c   Yamasaki, Hironori ^a   Akazawa, Shoichi ^a   Sakamaki, Hiroyuki ^a   Ishibashi, Miwa ^a   Abiru, Norio ^a   Uotani, Shigeo ^a   Matsuo, Hiroshi ^a   Yamaguchi, Yoshihiko ^a   Tokuyama, Kumpei ^b   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Sasebo Chuou Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INSULIN;

ADULT; ARTICLE; DIABETOGENESIS; DOSE RESPONSE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; ISLETS OF LANGERHANS; KINETICS; LIVER; MALE;

EID: 8944237507     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2621     Document Type: Article

References (39)

1. Venkatesan N, Davidson MB, Hutchinson A. 1987 Possible role for the glucose-fatty acid cycle in dexamethasone-induced insulin antagonism in rats. Metabolism. 36:883-891.
2. Perley M, Kipnis DM. 1965 Effect of glucocorticoids on plasma insulin. N Engl J Med. 274:1237-1241.
3. West KM. 1959 Response of the the blood glucose to glucocorticoids in man. Diabetes. 8:22-28.
4. Beard JC, Halter JB, Best JD, Pfeifer MA, Porte, Jr, D. 1984 Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am J Physiol 247:E592-E596.
5. Grill V, Pigon J, Hartling SG, Binder C, Efendic S. 1990 Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. Metabolism. 39:251-258.
6. Efendic S, Luft R, Wajngot A. 1984 Aspects of the pathogenesis of type 2 diabetes. Endocr Rev. 5:395-408.
7. Lieberman P, Patterson R, Kunske R. 1983 Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol. 72:1814-1820.
8. Bergman RN, Finegood DT, Ader M. 1985 Assessment of insulin sensitivity in vivo. Endocr Rev. 6:45-86.
9. Bergman RN. 1989 Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 38:1512-1527.
10. Martin IK, Christopher MJ, Alford FP, Best JD. 1991 Distinct but nonadditive effects of epinephrine and cortisol on determinants of glucose tolerance in dogs. Am J Physiol 260:E148-E153.
11. Sleeman MW, Christpher MJ, Martin IK, Ward GM, Alford FP, Best JD. 1992 Effects of acute and chronic counterregulatory hormone infusions on glucose tolerance and insulin sensitivity in diabetic dogs. Diabetes. 41:1446-1452.
12. Finegood DT, Hramiak IM, Dupre J. 1990 A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538-1549.
13. Taniguchi A, Nakai Y, Fukushima M, et al. 1992 Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes. 41:1540-1546.
14. Tokuyama K, Higaki Y, Fujitani J, et al. 1993 Intravenous glucose tolerance test-derived glucose effectiveness in physically trained humans. Am J Physiol 265:E298-303.
15. Bergman RN, Ider YZ, Bowden CR, Cobelli C. 1979 Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-677.
16. Pacini G, Bergman RN. 1986 MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed. 23:113-122.
17. Ader M, Bergman RN. 1994 Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am J Physiol 266:E17-25.
18. Ader M, Pacini G, Yang YJ, Bergman RN. 1985 Importance of glucose per se to intravenous glucose tolerance: comparison of the minimal-model prediction with measurement. Diabetes. 34:1092-1103.
19. Bergman RN, Prager R, Volund A, Olefsky JM. 1987 Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 79:790-800.
20. Beard JC, Bergman RN, Ward WK, Porte, Jr, D. 1986 The insulin sensitivity index in nondiabetic man: correlation between clamp-derived, and IVGTT-derived values. Diabetes 35:362-369.
21. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. 1989 Numerical Recipes in Pascal. New York: Cambridge University Press.
22. Bergman RN, Phillips LS, Cobelli C. 1981 Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 68:1456-1467.
23. Kahn SE, Prigeon RL, McCulloch DK, et al. 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 42:1663-1672.
24. Kahn SE, Prigeon RL, McCulloch DK, et al. 1994 The contribution of insulin-dependent and insulin independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes. 43:587-592.
25. Page R, Boolell M, Kalfas A, et al. 1991 Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis. Clin Endocrinol. 35:509-517.
26. Baron AD, Wallace P, Brechtel G. 1987 In vivo regulation of non-insulin-mediated glucose uptake by cortisol. Diabetes. 36:1230-1237.
27. Polonsky KS, Pugh W, Jaspan JB, et al. 1984 C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. J Clin Invest. 74:1821-1829.
28. Volund A, Polonsky KS, Bergman RN. 1987 Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes. 36:1195-1202.
29. Watanabe RM, Volund A, Roy S, Bergman RN. 1989 Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics. J Clin Endocrinol Metab. 69:790-797.
30. Ward WK, Johnston C, Beard JC, Benedetti TJ, Halter JB, Porte, Jr, D. 1985 Insulin resistance, and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes 34:861-869.
31. Johnston C, Raghu P, McCulloch DK, et al. 1987 β-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics. Diabetes. 36:829-837.
32. Kahn SE, Beard JC, Schwartz MW, et al. 1989 Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid- induced insulin resistance. Diabetes. 38:562-568.
33. Boyle P. 1993 Cushing's disease, glucocorticoid excess, glucocorticoid deficiency, and diabetes. Diabetes Reviews. 1:301-308.
34. Steele R. 1959 Influences of glucose loading and injected insulin on hepaticglucose output. Ann NY Acad Sci. 82:420-430.
35. Radziuk J, Norwich KH, Vranic M. 1974 Measurement and validation of non-steady turnover rates with applications to the insulin and glucose systems. Fed Proc. 33:1855-1864.
36. Lenzen S, Bailey CJ. 1984 Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans. Endocr Rev. 5:411-434.
37. Fajans SS, Conn JW. 1959 The early recognition of diabetes. Ann NY Acad Sci. 82:208 (Abstract).
38. O'Rahilly S, Turner RC, Matthews DR. 1988 Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med. 318:1225-1230.
39. Wajngot A, Giacca A, Grill V, Vranic M, Efendic S. 1992 The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders. Proc Natl Acad Sci USA. 89:6035-6039.